Impact Biomedical to execute 1-for-12.62 reverse stock split Sept. 23
Reuters2026/09/15 01:27Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Impact Biomedical set a 1-for-12.62 reverse stock split, effective Sept. 23, 2026.
- Shares will continue trading on NYSE American under IBO.
- Outstanding shares expected to drop to about 8,543,679 from about 107,821,231, subject to rounding.
- Merger terms with Zoar call for 1 Zoar share per 1 Impact share, calculated post-split.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609142126PRIMZONEFULLFEED9826821) on September 15, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sharp enters Japan AI server market, takes orders for Nvidia-powered systems
Reuters•2026/09/15 02:26
With a rate hike looming in September, will the US dollar start a new round of gains?
华尔街见闻•2026/09/15 02:24
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Dow Jones•2026/09/15 02:10
